Can Mid-Size Pharma Companies Ace the Race through COVID-19?
It is easy for a layperson to assume that the pharma industry is the one reaping benefits from the crisis. The truth, however, is that there is a lot...
Read More ⟶It is easy for a layperson to assume that the pharma industry is the one reaping benefits from the crisis. The truth, however, is that there is a lot...
Read More ⟶The application of Artificial Intelligence (AI) in sciences other than biomedical has been pretty successful and shows great promise for the future. In this article, we are trying to...
Read More ⟶We call it the new norm, yet we are unsure how it further unfolds its impact on people worldwide. That uncertains how the healthcare sector is going to pick...
Read More ⟶Needless to say that COVID 19 has been treacherous to the healthcare industry. Yes, there’s the obvious patient-angle. But beyond that, the overall healthcare system, including facilities and providers,...
Read More ⟶Effective countermeasures against exponential expansion of SARS-CoV-2 transmission are needed urgently to induce herd immunity and protect the most vulnerable population groups from COVID-19 infection. Induction of herd immunity...
Read More ⟶